162 related articles for article (PubMed ID: 21747614)
1. Efficacy of piroxicam patch compared to lidocaine patch for the treatment of postherpetic neuralgia.
Kim JY; Lim HJ; Lee WJ; Lee SJ; Kim DW; Kim BS
Ann Dermatol; 2011 May; 23(2):162-9. PubMed ID: 21747614
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study.
Meier T; Wasner G; Faust M; Kuntzer T; Ochsner F; Hueppe M; Bogousslavsky J; Baron R
Pain; 2003 Nov; 106(1-2):151-8. PubMed ID: 14581122
[TBL] [Abstract][Full Text] [Related]
3. Topical lidocaine for the treatment of postherpetic neuralgia.
Khaliq W; Alam S; Puri N
Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
[TBL] [Abstract][Full Text] [Related]
4. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
Davies PS; Galer BS
Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
6. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.
Galer BS; Rowbotham MC; Perander J; Friedman E
Pain; 1999 Apr; 80(3):533-538. PubMed ID: 10342414
[TBL] [Abstract][Full Text] [Related]
7. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial.
Katz NP; Gammaitoni AR; Davis MW; Dworkin RH;
Pain Med; 2002 Dec; 3(4):324-32. PubMed ID: 15099237
[TBL] [Abstract][Full Text] [Related]
8. The Treatment of Topical Drugs for Postherpetic Neuralgia: A Network Meta-Analysis.
Liu X; Wei L; Zeng Q; Lin K; Zhang J
Pain Physician; 2020 Nov; 23(6):541-551. PubMed ID: 33185370
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
10. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia.
Rowbotham MC; Davies PS; Verkempinck C; Galer BS
Pain; 1996 Apr; 65(1):39-44. PubMed ID: 8826488
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
[TBL] [Abstract][Full Text] [Related]
12. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
[TBL] [Abstract][Full Text] [Related]
13. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
[TBL] [Abstract][Full Text] [Related]
14. Postherpetic neuralgia: New hopes in prevention with adult vaccination and in treatment with a concentrated capsaicin patch.
Gawecka E; Viken O
Scand J Pain; 2012 Oct; 3(4):220-228. PubMed ID: 29913873
[TBL] [Abstract][Full Text] [Related]
15. Topical lidocaine gel relieves postherpetic neuralgia.
Rowbotham MC; Davies PS; Fields HL
Ann Neurol; 1995 Feb; 37(2):246-53. PubMed ID: 7847866
[TBL] [Abstract][Full Text] [Related]
16. Insufficient evidence to recommend topical lidocaine as first-line treatment for postherpetic neuralgia.
Zakrzewska JM
Evid Based Dent; 2007; 8(3):85-6. PubMed ID: 17891129
[TBL] [Abstract][Full Text] [Related]
17. Influence of anatomic location of lidocaine patch 5% on effectiveness and tolerability for postherpetic neuralgia.
Nalamachu S; Wieman M; Bednarek L; Chitra S
Patient Prefer Adherence; 2013; 7():551-7. PubMed ID: 23814464
[TBL] [Abstract][Full Text] [Related]
18. Lidocaine patch 5%.
Comer AM; Lamb HM
Drugs; 2000 Feb; 59(2):245-9; discussion 250-1. PubMed ID: 10730547
[TBL] [Abstract][Full Text] [Related]
19. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Postherpetic Neuralgia with 5% Topical Lidocaine Plaster – Experience from a Small County Hospital: Case Report.
Kontić M; Vičić-Hudorović V; Hudorović N
Acta Clin Croat; 2016 Dec; 55(4):655-658. PubMed ID: 29117658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]